Extensions

Patent Term Adjustments (PTA) and Patent Term Extensions (PTE)

US Patent 9281314 does not explicitly state any Patent Term Adjustments (PTA) or Patent Term Extensions (PTE) in the provided information.

• Patent Term Adjustment (PTA): PTA is granted to compensate applicants for delays incurred during the prosecution of a patent application before the United States Patent and Trademark Office (USPTO). These delays can be due to various factors, such as the USPTO failing to issue an office action within 14 months of filing, respond to a reply within four months, or issue a patent within 36 months of filing.
• Patent Term Extension (PTE): PTE is awarded to compensate for delays incurred in obtaining regulatory approval on a patented product or its manufacturing or usage methods, typically for pharmaceutical products.

Since this patent is for a semiconductor device, it is highly unlikely to have a PTE, as PTEs are generally related to regulatory approval processes for products like drugs. Any PTA would be detailed in the patent's prosecution history on the USPTO website.

Continuation Applications, Divisional Applications, and Related Family Members

The provided patent text and Google Patents information do not explicitly list any continuation applications, divisional applications, or other related family members for US Patent 9281314.

• Continuation Application: A continuation application is a second application for the same invention claimed in a prior nonprovisional application, filed before the original application becomes abandoned or patented, and claims priority from the parent application. They allow applicants to pursue additional claims to an invention already disclosed in an earlier application.
• Divisional Application: A divisional application is a type of continuing application that is directed to a different, distinct invention carved out of a pending application and discloses and claims only subject matter disclosed in the earlier or parent application.
• Continuation-in-Part (CIP) Application: A CIP application is filed during the lifetime of an earlier application by the same applicant, repeating some substantial portion or all of the earlier application and adding new matter not disclosed in the earlier case. A CIP cannot be retroactively converted into a divisional patent, especially if new matter was added.

To definitively determine if there are any continuation, divisional, or continuation-in-part applications, a detailed review of the patent's prosecution history on the USPTO website would be necessary. This would involve examining the "Parent Case Information" and "Continuity Data" sections.

Projected Expiration Date

The anticipated expiration date for US Patent 9281341 is October 10, 2034. This date is based on the general rule that the term of a patent (other than a design patent) is twenty years from the date on which the application for the patent was filed, or if priority is claimed, twenty years from the filing date of the earliest such application. Since the filing date for US9281314 is October 10, 2014, the standard 20-year term would lead to an expiration date of October 10, 2034.

The USPTO does not calculate expiration dates for patents but provides a calculator as a resource to help estimate them. Any PTA granted would extend this date, but without that specific information, the initial calculation stands.